These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3105046)

  • 21. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
    Sader HS; Huband MD; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients.
    Fleming PC; Knie B
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():169-73. PubMed ID: 19802981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
    Thabaut A; Durosoir JL; Saliou P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-Frequency transduction of imipenem resistance and high-frequency transduction of ceftazidime and aztreonam resistance by the bacteriophage AP-151 isolated from a Pseudomonas aeruginosa strain.
    Blahová J; Králiková K; Krcméry V; Jezek P
    J Chemother; 2000 Dec; 12(6):482-6. PubMed ID: 11154029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa.
    Philippon A; Paul G; Nevot P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():119-22. PubMed ID: 19810173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates.
    Buehrle DJ; Shields RK; Chen L; Hao B; Press EG; Alkrouk A; Potoski BA; Kreiswirth BN; Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 2016 May; 60(5):3227-31. PubMed ID: 26976862
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Fraile-Ribot PA; Mulet X; Cabot G; Del Barrio-Tofiño E; Juan C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam.
    Kresken M; Körber-Irrgang B
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899002
    [No Abstract]   [Full Text] [Related]  

  • 31. An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
    Bauernfeind A
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():111-7. PubMed ID: 19810172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters.
    Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2010 Nov; 65(11):2376-81. PubMed ID: 20801783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients.
    Chalhoub H; Tunney M; Elborn JS; Vergison A; Denis O; Plésiat P; Kahl BC; Van Bambeke F; Tulkens PM
    J Antimicrob Chemother; 2015 May; 70(5):1596-8. PubMed ID: 25587996
    [No Abstract]   [Full Text] [Related]  

  • 34. In-vitro study of the activity of ciprofloxacin combined with amikacin or ceftazidime against Pseudomonas aeruginosa.
    Farrag NN; Bendig JW; Talboys C; Azadian BS
    J Antimicrob Chemother; 1986 Dec; 18(6):770. PubMed ID: 3102448
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa.
    Cuffini AM; Carlone NA; Xerri L; Pizzoglio MF
    J Antimicrob Chemother; 1987 Aug; 20(2):261-71. PubMed ID: 3117762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
    Pechère JC; Vladoianu IR
    J Antimicrob Chemother; 1992 May; 29(5):563-73. PubMed ID: 1624394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
    Lim VK; Halijah MY
    Med J Malaysia; 2001 Sep; 56(3):365-9. PubMed ID: 11732084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.
    Sader HS; Castanheira M; Mendes RE; Flamm RK; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015; 59(6):3656-9. PubMed ID: 25845861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.